Medical Weight Loss Singapore: GLP-1 Treatment Guide 2025
Discover evidence-based GLP-1 weight loss treatments in Singapore — Wegovy, Ozempic & Saxenda. SMC-registered doctors, online consultation, real results.
Medical Weight Loss Singapore — GLP-1 Treatment Guide
What Is Medical Weight Loss — And Is It Right for You?
Struggling with weight despite diet and exercise is not a personal failing. Obesity is a chronic, complex medical condition influenced by hormones, genetics, and metabolism — and for many people, lifestyle changes alone are not enough. That's where medical weight loss in Singapore comes in.
Medical weight loss refers to clinically supervised programmes that combine evidence-based treatments — including prescription medications, dietary support, and health monitoring — to help you lose weight safely and sustainably. Unlike fad diets or over-the-counter supplements, medical weight loss is managed by licensed doctors who tailor treatment to your individual health profile.
In Singapore, the landscape of medical weight loss has transformed dramatically since the arrival of GLP-1 receptor agonists — a class of medications that have shown unprecedented results in clinical trials and real-world use. If you've heard terms like Wegovy Singapore, Ozempic, or GLP-1 injection, this guide will explain exactly what these treatments are, how they work, and how to access them safely through a licensed provider like Zoey.
Understanding GLP-1: The Science Behind the Breakthrough
What Is a GLP-1 Receptor Agonist?
GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in your gut after eating. It plays several key roles:
- Signals satiety — tells your brain you're full
- Slows gastric emptying — food moves more slowly through your stomach, reducing hunger spikes
- Regulates blood sugar — stimulates insulin release and suppresses glucagon
- Reduces food cravings — acts on reward pathways in the brain that drive overeating
GLP-1 receptor agonists are medications that mimic this hormone, amplifying its effects to support meaningful, sustained weight loss. Originally developed to treat Type 2 diabetes, they were found to produce significant weight reduction as a side effect — leading to dedicated obesity treatments being approved globally.
Why GLP-1 Medications Are Different
Previous weight loss medications often carried significant cardiovascular risks, psychiatric side effects, or were highly addictive. GLP-1 medications represent a genuinely new paradigm:
- They work with your body's own hormonal system
- They address the biological drivers of overeating, not just willpower
- They have strong cardiovascular safety data (several trials show reduced heart attack and stroke risk)
- They are reversible — effects normalise if you stop
GLP-1 Weight Loss Treatments Available in Singapore
Semaglutide (Wegovy / Ozempic)
Semaglutide is the active compound in both Wegovy and Ozempic. The difference: Ozempic is approved for Type 2 diabetes management, while Wegovy is specifically approved for chronic weight management — with higher doses optimised for weight loss.
In the landmark STEP trials:
- Participants lost an average of 15–17% of body weight over 68 weeks
- 70%+ of participants lost at least 10% of body weight
- Results were significantly better than placebo, with improved cardiovascular markers
Wegovy in Singapore is administered as a once-weekly subcutaneous injection using a pre-filled pen. Dose is titrated gradually (starting at 0.25 mg/week, increasing to a maintenance dose of 2.4 mg) to minimise side effects.
Regulatory note: Semaglutide-based treatments in Singapore are prescription-only medications regulated by the Health Sciences Authority (HSA). They must be prescribed by a Singapore Medical Council (SMC)-registered doctor following a clinical assessment.
Liraglutide (Saxenda)
Saxenda (liraglutide 3 mg) was the first GLP-1 medication approved specifically for weight management and has a longer track record in Singapore. It is a daily injection, making it slightly less convenient than once-weekly semaglutide, but it remains a valid option for some patients.
Clinical trial data (SCALE trials) shows:
- Average weight loss of 8–9% of body weight over 56 weeks
- Improved blood pressure, blood sugar, and cholesterol in many participants
Tirzepatide (Mounjaro)
Tirzepatide is a newer dual-action medication that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. Early data from the SURMOUNT trials suggests even greater weight loss than semaglutide alone — participants lost approximately 20–21% of body weight in the highest-dose arm.
Availability and approval status should be confirmed with your prescribing doctor, as the regulatory landscape for newer agents evolves.
Oral Semaglutide (Rybelsus)
For those who prefer not to self-inject, Rybelsus is an oral semaglutide tablet originally developed for Type 2 diabetes. While not approved specifically for obesity at current oral doses, doctors may discuss it as part of a broader metabolic health plan. Ask your Zoey doctor whether this is appropriate for your situation.
Am I a Candidate for GLP-1 Weight Loss Treatment?
GLP-1 medications are generally considered appropriate for adults who meet one of the following criteria:
| Criterion | Threshold |
|---|---|
| BMI (Body Mass Index) | ≥ 30 kg/m² (obesity) |
| BMI with weight-related conditions | ≥ 27 kg/m² with hypertension, pre-diabetes, dyslipidaemia, sleep apnoea, or NAFLD |
Weight-related conditions that may qualify you:
- Type 2 diabetes or pre-diabetes
- High blood pressure (hypertension)
- Abnormal cholesterol (dyslipidaemia)
- Obstructive sleep apnoea
- Polycystic ovary syndrome (PCOS)
- Non-alcoholic fatty liver disease (NAFLD)
- Osteoarthritis aggravated by weight
Who Should Not Take GLP-1 Medications?
GLP-1 medications are not suitable for everyone. Contraindications include:
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- Pregnancy or breastfeeding
- Severe gastrointestinal conditions (e.g., gastroparesis)
- Pancreatitis history (discuss with your doctor)
This is why a thorough medical assessment — as conducted by Zoey's SMC-registered doctors — is essential before starting treatment.
How Medical Weight Loss Works at Zoey Singapore
Zoey is a Singapore-based digital health platform that connects you with licensed, SMC-registered doctors for medical weight loss consultations and ongoing care. The process is designed to be clinically rigorous, discreet, and genuinely convenient.
Step 1: Online Health Assessment
Begin with a detailed health questionnaire covering your medical history, current medications, weight history, and goals. This lets your doctor prepare a thorough, personalised consultation — not a generic one-size-fits-all approach.
Step 2: Doctor Consultation
A licensed doctor reviews your assessment and conducts a video consultation (or in-person, depending on your preference). They will:
- Evaluate your eligibility for GLP-1 treatment
- Review your blood work (or order it if needed)
- Discuss treatment options, expected outcomes, and risks
- Answer all your questions
SMC compliance note: Zoey's doctors follow Singapore Medical Council guidelines, including the Ethical Code and Ethical Guidelines (ECEG). This means transparent communication about treatment options, risks, benefits, and costs — no pressure, no over-promising.
Step 3: Prescription and Medication Delivery
If GLP-1 treatment is appropriate, your doctor will issue a prescription through a licensed Singapore pharmacy. Medication is delivered discreetly to your home in temperature-controlled packaging.
Step 4: Ongoing Monitoring and Support
Medical weight loss is not a one-off prescription. At Zoey, ongoing care includes:
- Regular check-ins with your doctor (monthly or as needed)
- Dose titration management
- Side effect monitoring and management
- Nutritional and lifestyle guidance
- Progress tracking
This continuous support model is what distinguishes medical weight loss from simply obtaining a script — it's a structured programme designed for real, lasting results.
👉 Start your weight loss journey with Zoey Singapore
What Results Can You Expect?
Timeline of Weight Loss on GLP-1 Medications
Results vary, but here is a general timeline based on clinical trial data and real-world experience:
Weeks 1–4 (Dose Initiation) Most patients experience some appetite reduction. Weight loss may begin, though the main focus is tolerating the medication at a low starting dose. Nausea is common in this phase.
Months 2–3 Appetite suppression becomes more pronounced as the dose is titrated. Many patients report significantly reduced cravings, smaller portion sizes, and less interest in high-calorie foods. Average weight loss of 3–5% is common.
Months 4–6 This is when meaningful weight loss typically accelerates. Patients on full-dose semaglutide (Wegovy) are often seeing 8–12% weight loss in this window.
Months 7–12 and Beyond Continued loss toward the clinical trial average of 15–17% (semaglutide) or more. Weight maintenance becomes the focus once goals are achieved, with ongoing medication as a management tool, not a cure.
Beyond the Scale: Health Benefits
Weight loss of even 5–10% of body weight produces measurable health improvements:
- Blood pressure reduction (often enough to reduce or eliminate antihypertensives)
- Improved HbA1c — better blood sugar control in pre-diabetes and Type 2 diabetes
- Reduced joint pain — significant impact in those with obesity-related osteoarthritis
- Better sleep quality — reduced severity of obstructive sleep apnoea
- Improved mood and mental health — body image, energy, and self-esteem benefits
- Liver health — reduction in non-alcoholic fatty liver disease markers
Common Side Effects and How to Manage Them
GLP-1 medications are generally well tolerated, but side effects are common, especially during dose titration. Being prepared helps you get through this phase.
Gastrointestinal Side Effects (Most Common)
| Side Effect | Frequency | Management Tips |
|---|---|---|
| Nausea | Very common (40–50%) | Eat smaller meals, avoid fatty/rich foods, eat slowly |
| Vomiting | Common (15–25%) | Sip fluids, avoid lying down after eating |
| Diarrhoea | Common (20–30%) | Stay hydrated, eat bland foods |
| Constipation | Common (20–25%) | Increase fibre and water intake |
| Stomach discomfort | Common | Avoid large meals; graze instead |
Most GI side effects improve significantly after the first 4–8 weeks as your body adjusts. Slow, gradual dose titration (as prescribed) is the most effective way to minimise them.
Less Common Side Effects
- Injection site reactions — redness, bruising at the injection site; rotate sites
- Fatigue — typically short-term; ensure adequate hydration and nutrition
- Headache — usually resolves as dose adjusts
- Heart rate increase — a small increase is expected; inform your doctor if significant
When to Contact Your Doctor Immediately
- Severe persistent abdominal pain (possible pancreatitis)
- Signs of allergic reaction (rash, swelling, difficulty breathing)
- Visual changes or severe headaches
- Symptoms of thyroid problems (neck lump, difficulty swallowing)
At Zoey, you have ongoing access to your doctor for precisely these situations. Rapid escalation is built into the platform.
GLP-1 vs Other Weight Loss Approaches: A Comparison
| Approach | Average Weight Loss | Sustained Long-Term? | Requires Medical Supervision? |
|---|---|---|---|
| Diet & Exercise alone | 3–5% | Difficult to sustain | No |
| Orlistat (Xenical) | 3–5% | Moderate | Recommended |
| Phentermine | 5–8% | Short-term use only | Yes |
| Saxenda (Liraglutide) | 8–9% | Yes, with ongoing use | Yes |
| Wegovy (Semaglutide) | 15–17% | Yes, with ongoing use | Yes |
| Bariatric Surgery | 25–35% | Yes | Yes (surgical) |
GLP-1 medications occupy a compelling middle ground: substantially more effective than older medications or lifestyle alone, but far less invasive than surgery. For many people, they represent the most appropriate first step into medically managed weight loss.
Cost of GLP-1 Weight Loss Treatment in Singapore
Medication Costs
GLP-1 medications are prescription-only and represent a real cost commitment. Approximate monthly costs (as of 2025):
- Wegovy (semaglutide): SGD 400–600/month depending on dose
- Saxenda (liraglutide): SGD 350–500/month
- Tirzepatide (Mounjaro): SGD 500–700/month (verify current availability)
Note: Prices vary by pharmacy and dose. Zoey will provide transparent pricing at consultation.
Insurance and MediSave
As of publication, GLP-1 weight loss medications are generally not covered by MediSave or standard health insurance in Singapore for weight management indications. However:
- If you have a co-diagnosis of Type 2 diabetes, some coverage may apply
- Some corporate insurance plans cover obesity management — check your policy
- Zoey can provide documentation to assist with insurance claims where applicable
Consultation Fees
Zoey offers competitive, transparent consultation fees. Visit Zoey's weight loss page for current pricing.
Frequently Asked Questions (FAQ)
Yes. Semaglutide (under the brand name Wegovy, as well as Ozempic for diabetes) is available in Singapore through licensed medical providers. It is a prescription-only medication, meaning you must be assessed and prescribed by an SMC-registered doctor. Zoey's doctors can evaluate your eligibility and prescribe where appropriate.
Most patients begin to notice appetite reduction within the first 1–2 weeks. Measurable weight loss (2–5%) typically occurs within the first 4–8 weeks. Full results accumulate over 6–12 months as the dose is optimised. Clinical trials show average losses of 15–17% over approximately 16 months on semaglutide (Wegovy).
Wegovy and Saxenda are injected subcutaneously (under the skin) once weekly (Wegovy) or daily (Saxenda) using a small pre-filled pen. Most patients find the injections simple and nearly painless. Oral semaglutide (Rybelsus) exists but is currently approved only for diabetes management in Singapore — discuss with your Zoey doctor.
This is an important and honest question. GLP-1 medications work while you take them. Clinical data shows that weight regain does occur after stopping — on average, participants regained about two-thirds of lost weight within a year. This is why ongoing lifestyle changes (diet, exercise) during treatment are so important: they help preserve the progress made. Many patients and doctors view GLP-1 as long-term or indefinite therapy, similar to blood pressure or cholesterol medication.
Long-term safety data (up to 5+ years in some studies) is generally reassuring. The SELECT trial, which followed over 17,000 participants for up to approximately 3 years (median ~2.8 years), found that semaglutide reduced major cardiovascular events by 20%. Ongoing monitoring by your doctor is recommended as a best practice. Zoey's programme includes regular check-ins specifically to monitor your health throughout treatment.
You can consult with an SMC-registered Zoey doctor online, and if appropriate, receive a prescription that can be filled through a licensed Singapore pharmacy — with delivery to your home. You cannot legally obtain GLP-1 medications without a valid prescription from a licensed Singapore doctor. Beware of overseas online pharmacies or social media sellers offering these medications without a prescription — this is both illegal and potentially dangerous.
GLP-1 medications significantly reduce appetite, which naturally supports healthier eating. Your doctor may recommend dietary guidance to optimise results and reduce side effects. A lower-fat diet tends to minimise nausea during titration. There is no single mandatory diet — your Zoey doctor will discuss what works for your lifestyle.
PCOS (polycystic ovary syndrome) is often associated with insulin resistance and difficulty with weight management. GLP-1 medications have shown benefits in clinical studies for women with PCOS — not only supporting weight loss but potentially improving insulin sensitivity, menstrual regularity, and hormonal balance. Discuss your full hormonal health picture with your Zoey doctor.
Why Choose Zoey for Weight Loss Treatment in Singapore?
- SMC-registered doctors — all consultations conducted by fully licensed Singapore physicians
- Evidence-based protocols — treatment decisions based on current clinical guidelines and peer-reviewed evidence
- Discreet and convenient — consult from home; medication delivered to your door
- Ongoing care — not just a prescription, but a monitored programme with regular check-ins
- Transparent pricing — no hidden fees, no pressure
- Holistic approach — weight loss support alongside broader metabolic health management
Medical weight loss is a journey, not a quick fix. The right clinical team makes all the difference — and Zoey is designed to be exactly that: a trusted medical partner for sustainable results.
👉 Get started with Zoey — Medical Weight Loss Singapore
Conclusion
GLP-1 weight loss treatments have changed what is medically possible for people struggling with obesity and weight-related health conditions. With medications like Wegovy now accessible in Singapore through licensed medical providers, achieving meaningful, lasting weight loss is more achievable than ever before.
The key is doing it right: with a qualified doctor, appropriate monitoring, realistic expectations, and a commitment to lifestyle habits that support long-term success. Zoey provides exactly this — expert care, genuine convenience, and the clinical rigour that a medical treatment deserves.
If you're ready to explore whether GLP-1 treatment is right for you, the first step is simple: a confidential consultation with a licensed Zoey doctor.
References
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989–1002.
- Pi-Sunyer X, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE Obesity and Prediabetes). New England Journal of Medicine. 2015;373(1):11–22.
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387(3):205–216.
- Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). New England Journal of Medicine. 2023;389(24):2221–2232.
This article is for informational purposes only and does not constitute medical advice. All treatments require a consultation with and prescription from a licensed Singapore Medical Council (SMC)-registered doctor. Individual results vary. Zoey complies with SMC Ethical Code and Ethical Guidelines.